Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
49
GTMEF Quote, Financials, Valuation and Earnings
Last price:
$41.95
Seasonality move
:
9.91%
Day range:
$41.95 - $41.95
52-week range:
$33.60 - $41.95
Dividend yield:
4.15%
P/E ratio:
15.27x
P/S ratio:
1.97x
P/B ratio:
2.05x
Volume:
--
Avg. volume:
--
1-year change:
24.85%
Market cap:
$6.1B
Revenue:
$3.1B
EPS (TTM):
$2.75
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.4B | $3.2B | $3.2B | $3.1B | |
| Revenue Growth (YoY) | 0.54% | 5.64% | -6.02% | 0.68% | -2.72% | |
| Cost of Revenues | $351.2M | $375.3M | $349.9M | $351.8M | $314.6M | |
| Gross Profit | $2.9B | $3B | $2.9B | $2.9B | $2.8B | |
| Gross Profit Margin | 89.15% | 89.03% | 89.12% | 89.13% | 90.01% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $592.7M | $653.8M | $674.9M | $641.8M | $599.5M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2B | $2.2B | $2.2B | $2.2B | $2.2B | |
| Operating Income | $857M | $801.6M | $661.7M | $678.4M | $672.2M | |
| Net Interest Expenses | $128.6M | $196.3M | $158.1M | $197.2M | $230.2M | |
| EBT. Incl. Unusual Items | $547.4M | $589.5M | $809.9M | $582.3M | $528.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $171.8M | $107.9M | $174.4M | $140.8M | $105.4M | |
| Net Income to Company | $547.4M | $589.5M | $809.9M | $582.3M | $528.8M | |
| Minority Interest in Earnings | -$902.1K | -$1.4M | -$753.6K | -$1.2M | $325.4K | |
| Net Income to Common Excl Extra Items | $374.7M | $480.1M | $634.7M | $440.3M | $423.7M | |
| Basic EPS (Cont. Ops) | $2.72 | $3.52 | $4.51 | $2.88 | $2.76 | |
| Diluted EPS (Cont. Ops) | $2.71 | $3.50 | $4.49 | $2.87 | $2.75 | |
| Weighted Average Basic Share | $133.4M | $133.6M | $135.5M | $144.2M | $144.3M | |
| Weighted Average Diluted Share | $134.4M | $134.6M | $136.4M | $145.1M | $145.3M | |
| EBITDA | $1.4B | $1.6B | $1.8B | $1.6B | $1.7B | |
| EBIT | $669.5M | $730.2M | $966.9M | $790.5M | $772M | |
| Revenue (Reported) | $3.2B | $3.4B | $3.2B | $3.2B | $3.1B | |
| Operating Income (Reported) | $857M | $801.6M | $661.7M | $678.4M | $672.2M | |
| Operating Income (Adjusted) | $669.5M | $730.2M | $966.9M | $790.5M | $772M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $887.3M | $842.2M | $820.7M | $808.7M | $753.1M | |
| Revenue Growth (YoY) | 9.56% | -5.08% | -2.55% | -1.46% | -6.87% | |
| Cost of Revenues | $118.9M | $97.8M | $104.1M | $80.8M | $75.1M | |
| Gross Profit | $768.4M | $744.4M | $716.5M | $727.8M | $678M | |
| Gross Profit Margin | 86.6% | 88.39% | 87.31% | 90% | 90.03% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $164.5M | $153.5M | $156.3M | $148M | $139.3M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $559M | $546.7M | $527.2M | $550.3M | $537.4M | |
| Operating Income | $209.4M | $197.7M | $189.3M | $177.5M | $140.6M | |
| Net Interest Expenses | $31.4M | $53.1M | $46.9M | $53.5M | $63.4M | |
| EBT. Incl. Unusual Items | $161.9M | $327.3M | $178M | $154.6M | $142.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $10M | $63.1M | $45.5M | $33.3M | $22.1M | |
| Net Income to Company | $161.9M | $327.3M | $178M | $154.6M | $142.1M | |
| Minority Interest in Earnings | -$611.8K | -$327.5K | -$341.7K | $226.5K | $52.8K | |
| Net Income to Common Excl Extra Items | $151.3M | $263.8M | $132.2M | $121.5M | $120.1M | |
| Basic EPS (Cont. Ops) | $1.09 | $1.97 | $0.87 | $0.80 | $0.79 | |
| Diluted EPS (Cont. Ops) | $1.09 | $1.95 | $0.86 | $0.80 | $0.79 | |
| Weighted Average Basic Share | $135.6M | $133.6M | $144.1M | $144.2M | $144.4M | |
| Weighted Average Diluted Share | $136.6M | $134.6M | $145M | $145.2M | $145.3M | |
| EBITDA | $381.8M | $579M | $430M | $430.5M | $438.8M | |
| EBIT | $191.9M | $365.3M | $226.7M | $210.9M | $207.5M | |
| Revenue (Reported) | $887.3M | $842.2M | $820.7M | $808.7M | $753.1M | |
| Operating Income (Reported) | $209.4M | $197.7M | $189.3M | $177.5M | $140.6M | |
| Operating Income (Adjusted) | $191.9M | $365.3M | $226.7M | $210.9M | $207.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $3.4B | $3.2B | $3.2B | $3.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $375.7M | $355M | $360.2M | $328.8M | $308.7M | |
| Gross Profit | $2.9B | $3B | $2.8B | $2.9B | $2.8B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $624M | $638.6M | $671.8M | $633.6M | $590.4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.1B | $2.2B | $2.2B | $2.2B | $2.1B | |
| Operating Income | $819M | $790.6M | $655.6M | $667.1M | $635.5M | |
| Net Interest Expenses | $131.4M | $216.4M | $150.7M | $203.8M | $239.9M | |
| EBT. Incl. Unusual Items | $516.3M | $755.7M | $666.1M | $559.8M | $517.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $120.7M | $160.9M | $157.4M | $128.8M | $94.3M | |
| Net Income to Company | $519.9M | $754.8M | $660.6M | $558.8M | $516.3M | |
| Minority Interest in Earnings | -$1.3M | -$1.2M | -$784.4K | -$607.2K | $156.5K | |
| Net Income to Common Excl Extra Items | $394.4M | $593.6M | $507.9M | $430.3M | $423M | |
| Basic EPS (Cont. Ops) | $2.87 | $4.36 | $3.45 | $2.82 | $2.76 | |
| Diluted EPS (Cont. Ops) | $2.85 | $4.34 | $3.43 | $2.81 | $2.75 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.4B | $1.8B | $1.7B | $1.6B | $1.7B | |
| EBIT | $639.7M | $904.2M | $832.8M | $775.7M | $769.1M | |
| Revenue (Reported) | $3.3B | $3.4B | $3.2B | $3.2B | $3.1B | |
| Operating Income (Reported) | $819M | $790.6M | $655.6M | $667.1M | $635.5M | |
| Operating Income (Adjusted) | $639.7M | $904.2M | $832.8M | $775.7M | $769.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $887.3M | $842.2M | $820.7M | $808.7M | $753.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $118.9M | $97.8M | $104.1M | $80.8M | $75.1M | |
| Gross Profit | $768.4M | $744.4M | $716.5M | $727.8M | $678M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $164.5M | $153.5M | $156.3M | $148M | $139.3M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $559M | $546.7M | $527.2M | $550.3M | $537.4M | |
| Operating Income | $209.4M | $197.7M | $189.3M | $177.5M | $140.6M | |
| Net Interest Expenses | $31.4M | $53.1M | $46.9M | $53.5M | $63.4M | |
| EBT. Incl. Unusual Items | $161.9M | $327.3M | $178M | $154.6M | $142.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $10M | $63.1M | $45.5M | $33.3M | $22.1M | |
| Net Income to Company | $161.9M | $327.3M | $178M | $154.6M | $142.1M | |
| Minority Interest in Earnings | -$611.8K | -$327.5K | -$341.7K | $226.5K | $52.8K | |
| Net Income to Common Excl Extra Items | $151.3M | $263.8M | $132.2M | $121.5M | $120.1M | |
| Basic EPS (Cont. Ops) | $1.09 | $1.97 | $0.87 | $0.80 | $0.79 | |
| Diluted EPS (Cont. Ops) | $1.09 | $1.95 | $0.86 | $0.80 | $0.79 | |
| Weighted Average Basic Share | $135.6M | $133.6M | $144.1M | $144.2M | $144.4M | |
| Weighted Average Diluted Share | $136.6M | $134.6M | $145M | $145.2M | $145.3M | |
| EBITDA | $381.8M | $579M | $430M | $430.5M | $438.8M | |
| EBIT | $191.9M | $365.3M | $226.7M | $210.9M | $207.5M | |
| Revenue (Reported) | $887.3M | $842.2M | $820.7M | $808.7M | $753.1M | |
| Operating Income (Reported) | $209.4M | $197.7M | $189.3M | $177.5M | $140.6M | |
| Operating Income (Adjusted) | $191.9M | $365.3M | $226.7M | $210.9M | $207.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $406.2M | $471.8M | $282.8M | $300.3M | $365.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $419.4M | $325M | $423.1M | $326.5M | $336.9M | |
| Inventory | $124.7M | $78.7M | $69.7M | $61.1M | $50.8M | |
| Prepaid Expenses | $239.4M | $271.7M | -- | -- | -- | |
| Other Current Assets | -- | -- | $353.9M | $390.4M | $342.2M | |
| Total Current Assets | $1.3B | $1.3B | $1.8B | $1.6B | $1.3B | |
| Property Plant And Equipment | $4.1B | $5.7B | $5.7B | $7.3B | $7.6B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $65.6M | $60.5M | $55.8M | $31.3M | $28.8M | |
| Other Intangibles | $289.5M | $343.6M | $394.6M | $390.4M | $316.1M | |
| Other Long-Term Assets | $528M | $670.5M | $935M | $641.6M | $468.2M | |
| Total Assets | $7.1B | $8.9B | $10B | $11B | $10.9B | |
| Accounts Payable | $265.2M | $117.5M | $153.8M | $138.2M | $146.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $20.8M | $71.3M | $81.2M | $106.4M | $140.1M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.7B | $2.3B | $2.8B | $2.6B | $2.1B | |
| Long-Term Debt | $3.3B | $3.8B | $3.4B | $3.8B | $3.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.4B | $6.7B | $7.2B | $8.1B | $8B | |
| Common Stock | $176.2M | $164.9M | $161.5M | $162.4M | $154.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $1.7B | $2.2B | $2.7B | $2.9B | $2.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $4.9M | $5.7M | $6.2M | $1M | $528.8K | |
| Total Equity | $1.7B | $2.2B | $2.7B | $2.9B | $2.9B | |
| Total Liabilities and Equity | $7.1B | $8.9B | $10B | $11B | $10.9B | |
| Cash and Short Terms | $406.2M | $471.8M | $282.8M | $300.3M | $365.9M | |
| Total Debt | $3.4B | $4.1B | $4.2B | $4.5B | $4.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $298.5M | $284.7M | $299M | $302.1M | $326.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $386.4M | $346.5M | $407.3M | $309.5M | $304.1M | |
| Inventory | $114.2M | $88.3M | $97.6M | $47.7M | $47.3M | |
| Prepaid Expenses | $285.8M | $397.8M | $451.1M | -- | -- | |
| Other Current Assets | -- | -- | -- | $400.3M | $355.5M | |
| Total Current Assets | $1.2B | $1.3B | $1.8B | $1.5B | $1.3B | |
| Property Plant And Equipment | $4.3B | $5.7B | $6.3B | $7.4B | $7.8B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $64M | $59.6M | $57.2M | $30.9M | $19.9M | |
| Other Intangibles | $300.5M | $390.3M | $393.2M | $362.2M | $318.2M | |
| Other Long-Term Assets | $565.5M | $654.6M | $988.3M | $607.9M | $454.4M | |
| Total Assets | $7.3B | $9.2B | $10.7B | $11B | $11.1B | |
| Accounts Payable | $201.7M | $249.8M | $156M | $144.5M | $162.4M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $90.2M | $72.8M | $124.8M | $140.7M | $156.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.6B | $2.3B | $3.1B | $2.7B | $2B | |
| Long-Term Debt | $3.4B | $3.9B | $3.4B | $3.6B | $3.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.5B | $6.8B | $7.8B | $8.1B | $8.1B | |
| Common Stock | $174.4M | $162.4M | $165.6M | $160.2M | $157M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $5.3M | $5.9M | $6.8M | $656.6K | $876.7K | |
| Total Equity | $1.8B | $2.4B | $2.9B | $2.9B | $3B | |
| Total Liabilities and Equity | $7.3B | $9.2B | $10.7B | $11B | $11.1B | |
| Cash and Short Terms | $298.5M | $284.7M | $299M | $302.1M | $326.3M | |
| Total Debt | $3.5B | $4.2B | $4.3B | $4.4B | $4.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $547.4M | $589.5M | $809.9M | $582.3M | $528.8M | |
| Depreciation & Amoritzation | $714.3M | $835M | $838.4M | $850.6M | $879.9M | |
| Stock-Based Compensation | $8M | $8.9M | $8.1M | $5.1M | $6.6M | |
| Change in Accounts Receivable | -$73.3M | -$43.3M | -$197.6M | -$41.6M | -$38M | |
| Change in Inventories | -$31.5M | $29.3M | -$1.5M | $1.6M | $4.7M | |
| Cash From Operations | $1.3B | $1.3B | $1.2B | $1.4B | $1.5B | |
| Capital Expenditures | $1.2B | $1.9B | $1.9B | $1.3B | $979.6M | |
| Cash Acquisitions | -$38.7M | -$32.3M | $81.6M | -$57.6M | -$4.7M | |
| Cash From Investing | -$1.2B | -$2B | -$1.4B | -$978.6M | -$536M | |
| Dividends Paid (Ex Special Dividend) | -$302M | -$304.4M | -$290.1M | -$283.8M | -$276.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.3B | $1.9B | $1.7B | $1.9B | $877.1M | |
| Long-Term Debt Repaid | -$618.6M | -$1B | -$1.3B | -$1.6B | -$923.4M | |
| Repurchase of Common Stock | -- | -$203M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $171.2M | $732M | $40.5M | -$495M | -$862.3M | |
| Beginning Cash (CF) | $167.4M | $396M | $445.1M | $323.9M | $290.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $243.6M | $94.2M | -$119.2M | -$28.6M | $79.8M | |
| Ending Cash (CF) | $393.5M | $492M | $331.2M | $299M | $372.3M | |
| Levered Free Cash Flow | $98M | -$561.6M | -$665M | $176.4M | $498.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $161.9M | $327.3M | $178M | $154.6M | $142.1M | |
| Depreciation & Amoritzation | $190M | $213.6M | $203.3M | $219.5M | $231.3M | |
| Stock-Based Compensation | $1.7M | $1.3M | $1.4M | $2.1M | $1.6M | |
| Change in Accounts Receivable | -$14.8M | -$52.2M | -$5.3M | -$595.7K | $7.2M | |
| Change in Inventories | $7.6M | -$13M | -$27M | $12.1M | $2.6M | |
| Cash From Operations | $347M | $235.8M | $247.8M | $421.6M | $391.3M | |
| Capital Expenditures | $395.9M | $405.9M | $320.5M | $245.4M | $145.6M | |
| Cash Acquisitions | -- | -$2.8M | -$4M | -$2.4M | -- | |
| Cash From Investing | -$394.1M | -$407.6M | -$169.3M | -$155.5M | -$105.6M | |
| Dividends Paid (Ex Special Dividend) | -$80M | -$69.8M | -$65.6M | -$64.4M | -$62.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $229.9M | $189.9M | $321M | $54.1M | $172.1M | |
| Long-Term Debt Repaid | -$158.4M | -$61.4M | -$271.8M | -$126.4M | -$288.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$57.4M | -$14M | -$112.3M | -$260.7M | -$321.9M | |
| Beginning Cash (CF) | $404M | $468.7M | $328.7M | $297.1M | $367.5M | |
| Foreign Exchange Rate Adjustment | $499.4K | $4.4M | $1.2M | $526.1K | -$711.5K | |
| Additions / Reductions | -$104.5M | -$185.9M | -$33.8M | $5.4M | -$36.2M | |
| Ending Cash (CF) | $299.9M | $287.2M | $296M | $303.1M | $322.3M | |
| Levered Free Cash Flow | -$48.9M | -$170.2M | -$72.7M | $176.3M | $245.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $519.9M | $754.8M | $660.6M | $558.8M | $516.3M | |
| Depreciation & Amoritzation | $734.4M | $858.6M | $828M | $866.9M | $891.7M | |
| Stock-Based Compensation | $8.4M | $8.6M | $8.2M | $5.9M | $6M | |
| Change in Accounts Receivable | -$41.6M | -$80.8M | -$150.6M | -$36.9M | -$30.2M | |
| Change in Inventories | -$41.9M | $8.7M | -$15.5M | $40.7M | -$4.9M | |
| Cash From Operations | $1.4B | $1.2B | $1.2B | $1.6B | $1.4B | |
| Capital Expenditures | $1.4B | $1.9B | $1.8B | $1.2B | $879.9M | |
| Cash Acquisitions | -$38M | -$35.2M | $80.5M | -$56M | -$2.3M | |
| Cash From Investing | -$1.4B | -$2B | -$1.1B | -$964.9M | -$486M | |
| Dividends Paid (Ex Special Dividend) | -$306.2M | -$294.2M | -$286M | -$282.5M | -$274.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.3B | $1.8B | $1.8B | $1.7B | $995.1M | |
| Long-Term Debt Repaid | -$744.7M | -$923.3M | -$1.5B | -$1.5B | -$1.1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $56.2M | $775.4M | -$57.8M | -$643.4M | -$923.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $14M | $12.8M | $32.8M | $10.7M | $38.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$11.8M | -$682.8M | -$567.6M | $425.4M | $567.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $161.9M | $327.3M | $178M | $154.6M | $142.1M | |
| Depreciation & Amoritzation | $190M | $213.6M | $203.3M | $219.5M | $231.3M | |
| Stock-Based Compensation | $1.7M | $1.3M | $1.4M | $2.1M | $1.6M | |
| Change in Accounts Receivable | -$14.8M | -$52.2M | -$5.3M | -$595.7K | $7.2M | |
| Change in Inventories | $7.6M | -$13M | -$27M | $12.1M | $2.6M | |
| Cash From Operations | $347M | $235.8M | $247.8M | $421.6M | $391.3M | |
| Capital Expenditures | $395.9M | $405.9M | $320.5M | $245.4M | $145.6M | |
| Cash Acquisitions | -- | -$2.8M | -$4M | -$2.4M | -- | |
| Cash From Investing | -$394.1M | -$407.6M | -$169.3M | -$155.5M | -$105.6M | |
| Dividends Paid (Ex Special Dividend) | -$80M | -$69.8M | -$65.6M | -$64.4M | -$62.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $229.9M | $189.9M | $321M | $54.1M | $172.1M | |
| Long-Term Debt Repaid | -$158.4M | -$61.4M | -$271.8M | -$126.4M | -$288.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$57.4M | -$14M | -$112.3M | -$260.7M | -$321.9M | |
| Beginning Cash (CF) | $404M | $468.7M | $328.7M | $297.1M | $367.5M | |
| Foreign Exchange Rate Adjustment | $499.4K | $4.4M | $1.2M | $526.1K | -$711.5K | |
| Additions / Reductions | -$104.5M | -$185.9M | -$33.8M | $5.4M | -$36.2M | |
| Ending Cash (CF) | $299.9M | $287.2M | $296M | $303.1M | $322.3M | |
| Levered Free Cash Flow | -$48.9M | -$170.2M | -$72.7M | $176.3M | $245.7M | |
Get GTMEF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GTMEF
Sector
P/E ratio
15.27x
17.70x
PEG ratio
--
0.00x
P/B ratio
2.05x
1.49x
Price / LTM sales
1.97x
0.96x
Growth Metrics
GTMEF
Sector
Revenue growth
-6.87%
-0.53%
Earnings growth
-1.3%
-0.61%
Revenue (5-year growth)
-0.45%
1.59%
Earnings forecast
--
$0.05
Profitability
GTMEF
Sector
Profitability FY 2024
$2.8B
$256.3M
Return on invested capital
5.87%
0.79%
Return on assets
3.86%
0.12%
Return on equity
14.49%
2.1%
Earnings Date
Last Earnings Date
Jul
18
Next Earnings Date
Jul
18
Estimated Next Earnings Date
Oct
17
Balance Sheet
GTMEF
Sector
Total cash
$326.3M
$97.1M
Short term investments
--
$26.8M
Total assets
$10.9B
$827.5M
Long term debt
$4.2B
$44M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
